[go: up one dir, main page]

UA85707C2 - Бензоксазины для лечения заболеваний дыхательных путей - Google Patents

Бензоксазины для лечения заболеваний дыхательных путей

Info

Publication number
UA85707C2
UA85707C2 UAA200612036A UAA200612036A UA85707C2 UA 85707 C2 UA85707 C2 UA 85707C2 UA A200612036 A UAA200612036 A UA A200612036A UA A200612036 A UAA200612036 A UA A200612036A UA 85707 C2 UA85707 C2 UA 85707C2
Authority
UA
Ukraine
Prior art keywords
respiratory tract
benzoxazines
treating respiratory
tract diseases
relates
Prior art date
Application number
UAA200612036A
Other languages
English (en)
Ukrainian (uk)
Inventor
Т'єрі Буісу
Інго Конетцкі
Забіне Пестель
Андреас Шнапп
Крістоф Хьонке
Філіпп Лустенбергер
Клаус Рудольф
Курт Шромм
Франк Бюттнер
Клаудіа Хайне
Херманн Шолленбергер
Original Assignee
Бьорінгер Інгельхайм Інтернаціональ Гмбх
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Бьорінгер Інгельхайм Інтернаціональ Гмбх filed Critical Бьорінгер Інгельхайм Інтернаціональ Гмбх
Publication of UA85707C2 publication Critical patent/UA85707C2/ru

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
    • A61K31/5375—1,4-Oxazines, e.g. morpholine
    • A61K31/538—1,4-Oxazines, e.g. morpholine ortho- or peri-condensed with carbocyclic ring systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/08—Bronchodilators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10—Antimycotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Pulmonology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Epidemiology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Virology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)

Abstract

В заявке описано применение соединений общей формулы 1 EMBED ISISServer , 1 в которой остатки R1, R2 и R3 могут иметь отмеченные в формуле изобретения и в описании значения, для получения лекарственного средства, предназначенного для лечения заболеваний дыхательных путей.
UAA200612036A 2004-04-22 2005-04-18 Бензоксазины для лечения заболеваний дыхательных путей UA85707C2 (ru)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE102004019539A DE102004019539A1 (de) 2004-04-22 2004-04-22 Neue Arzneimittel zur Behandlung von Atemwegserkrankungen

Publications (1)

Publication Number Publication Date
UA85707C2 true UA85707C2 (ru) 2009-02-25

Family

ID=34966948

Family Applications (1)

Application Number Title Priority Date Filing Date
UAA200612036A UA85707C2 (ru) 2004-04-22 2005-04-18 Бензоксазины для лечения заболеваний дыхательных путей

Country Status (20)

Country Link
EP (1) EP1765355B1 (ru)
JP (1) JP2007533684A (ru)
KR (2) KR20130042662A (ru)
CN (1) CN1946406A (ru)
AU (1) AU2005235420C1 (ru)
BR (1) BRPI0510084A (ru)
CA (1) CA2559700C (ru)
DE (1) DE102004019539A1 (ru)
DK (1) DK1765355T3 (ru)
EA (1) EA012045B1 (ru)
EC (1) ECSP066948A (ru)
ES (1) ES2403184T3 (ru)
IL (1) IL177663A (ru)
NO (1) NO20065061L (ru)
NZ (1) NZ551272A (ru)
PL (1) PL1765355T3 (ru)
SG (1) SG152233A1 (ru)
UA (1) UA85707C2 (ru)
WO (1) WO2005102350A1 (ru)
ZA (1) ZA200606547B (ru)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7056916B2 (en) 2002-11-15 2006-06-06 Boehringer Ingelheim Pharma Gmbh & Co. Kg Medicaments for the treatment of chronic obstructive pulmonary disease
DE102004024452A1 (de) * 2004-05-14 2005-12-08 Boehringer Ingelheim Pharma Gmbh & Co. Kg Aerosolformulierung für die Inhalation von Betaagonisten
US7220742B2 (en) 2004-05-14 2007-05-22 Boehringer Ingelheim International Gmbh Enantiomerically pure beta agonists, process for the manufacture thereof and use thereof as medicaments
PL1917253T3 (pl) 2005-08-15 2015-06-30 Boehringer Ingelheim Int Sposób wytwarzania betamimetyków
JP2009514933A (ja) * 2005-11-09 2009-04-09 ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング 吸入用エアロゾル製剤
GB0601951D0 (en) 2006-01-31 2006-03-15 Novartis Ag Organic compounds
EP2231642B1 (en) 2008-01-11 2013-10-23 Novartis AG Pyrimidines as kinase inhibitors
WO2012034095A1 (en) 2010-09-09 2012-03-15 Irm Llc Compounds and compositions as trk inhibitors
US8637516B2 (en) 2010-09-09 2014-01-28 Irm Llc Compounds and compositions as TRK inhibitors
PH12013501758A1 (en) 2011-02-25 2013-10-14 Irm Llc Pyrazolo [1,5-a] pyridines as trk inhibitors
WO2014108449A1 (en) 2013-01-08 2014-07-17 Atrogi Ab A screening method, a kit, a method of treatment and a compound for use in a method of treatment
EP3551187B1 (en) 2016-12-12 2021-02-17 Boehringer Ingelheim International GmbH Nintedanib for use in methods for the treatment of interstitial lung diseases by coadministration with olodaterol
GB201714740D0 (en) 2017-09-13 2017-10-25 Atrogi Ab New compounds and uses
GB201714736D0 (en) 2017-09-13 2017-10-25 Atrogi Ab New compounds and uses
GB201714745D0 (en) 2017-09-13 2017-10-25 Atrogi Ab New compounds and uses
GB201714734D0 (en) 2017-09-13 2017-10-25 Atrogi Ab New compounds and uses
GB202205895D0 (en) 2022-04-22 2022-06-08 Atrogi Ab New medical uses
WO2024153813A1 (en) 2023-01-20 2024-07-25 Atrogi Ab Beta 2-adrenergic receptor agonists for treatment or prevention of muscle wasting
GB202302225D0 (en) 2023-02-16 2023-04-05 Atrogi Ab New medical uses
GB202303229D0 (en) 2023-03-06 2023-04-19 Atrogi Ab New medical uses

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4460581A (en) 1982-10-12 1984-07-17 Boehringer Ingelheim Kg (1-Hydroxy-2-amino-alkyl)-substituted benzoxazinones and benzoxazolinones
EA200201056A1 (ru) * 2000-04-27 2003-04-24 Бёрингер Ингельхайм Фарма Кг Новые, обладающие продолжительным действием бетамиметики, способ их получения и их применение в качестве лекарственных средств
DE10130371A1 (de) * 2001-06-23 2003-01-02 Boehringer Ingelheim Pharma Neue Arzneimittelkompositionen auf der Basis von Anticholinergika, Corticosteroiden und Betamimetika
DE10253282A1 (de) * 2002-11-15 2004-05-27 Boehringer Ingelheim Pharma Gmbh & Co. Kg Neue Arzneimittel zur Behandlung von chronisch obstruktiver Lungenerkrankung

Also Published As

Publication number Publication date
DE102004019539A1 (de) 2005-11-10
JP2007533684A (ja) 2007-11-22
BRPI0510084A (pt) 2007-10-16
KR20130042662A (ko) 2013-04-26
WO2005102350A1 (de) 2005-11-03
EA012045B1 (ru) 2009-08-28
CA2559700A1 (en) 2005-11-03
CN1946406A (zh) 2007-04-11
KR101338947B1 (ko) 2013-12-10
ZA200606547B (en) 2008-04-30
AU2005235420A1 (en) 2005-11-03
NO20065061L (no) 2006-11-07
SG152233A1 (en) 2009-05-29
EA200601837A1 (ru) 2007-04-27
AU2005235420C1 (en) 2011-02-24
ECSP066948A (es) 2006-12-20
EP1765355B1 (de) 2013-03-06
DK1765355T3 (da) 2013-04-08
ES2403184T3 (es) 2013-05-16
PL1765355T3 (pl) 2013-08-30
IL177663A0 (en) 2006-12-31
AU2005235420B2 (en) 2010-10-28
KR20070054599A (ko) 2007-05-29
NZ551272A (en) 2010-10-29
EP1765355A1 (de) 2007-03-28
CA2559700C (en) 2013-06-11
IL177663A (en) 2014-04-30

Similar Documents

Publication Publication Date Title
UA85707C2 (ru) Бензоксазины для лечения заболеваний дыхательных путей
TW200738242A (en) Dihydropteridinones in the treatment of respiratory diseases
ZA200810113B (en) Method for the treatment and prevention of ocular disorders
GEP20084551B (en) 4-phenylamino-quinazolin-6-yl-amides
MX2009006742A (es) Inhibidores acilaminopirazoles como fgfr.
UA85708C2 (ru) Лекарственные комбинации, содержащие бензоксазины, для лечения заболеваний дыхательных путей
IS2517B (is) Notkun á setnum 2-amínótetralínum í fyrirbyggjandi meðferð á Parkinsons-veiki
MX2007000505A (es) Derivados de oxindol sustituidos y medicamentos que contienen los mismos.
HK1091121A1 (en) Substituted 2-aminotetralins for the treatment of depressions
TW200612910A (en) Medicaments comprising carbonyl compounds, and the use thereof
DE50311898D1 (de) Fredericamycin-derivate als arzneimittel zur tumorbehandlung
IL195256A0 (en) Compositions of r(+)and s(-)pramipexole and methods of using the same
WO2007112014A3 (en) New therapeutic combinations for the treatment of depression
TW200716547A (en) Piperidin-4-yl-amide derivatives
IL183636A0 (en) Quinoline derivative, use and production thereof, and drug containing the same
TW200640911A (en) Novel, long acting betamimetics for the treatment of respiratory diseases
UA96969C2 (en) Acylaminopyrazoles as fgfr inhibitors
MXPA06013039A (es) El tratamiento de enfermedad respiratoria.
MY146802A (en) Novel drugs for treating respiratory diseases
TW200604196A (en) New quinuclidine derivatives and pharmaceutical compositions comprising them
PL1809288T3 (pl) Zastosowanie pochodnych 1,4-bis-(3-aminoalkilo)piperazyny do leczenia chorób neurodegeneracyjnych
TW200635595A (en) Medicaments for the treatment of prevention of fibrotic diseases
MX2009005912A (es) Derivados de etilamina-fenilo heterociclilo sustituidos, su preparacion y uso como medicamentos.
TW200609222A (en) Diazole derivatives
MXPA06000995A (es) Amidas novedosas de acido indolil-3-glioxilico sustituidas en el atomo de n, uso de las mismas como medicamento y metodo para la produccion de las mismas.